Kenjiro Aogi

Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)

Jun Masuda, Hitomi Sakai, Junji Tsurutani et al. · Journal for ImmunoTherapy of Cancer · 2023 · 59 citations · Full text

Factors Associated with Health-related Quality-of-life in Breast Cancer Survivors: Influence of the Type of Surgery

Shozo Ohsumi, Kojiro Shimozuma, Satoshi Morita et al. · Japanese Journal of Clinical Oncology · 2009 · 50 citations

Frequency and component analysis of contaminants generated in preparation of anticancer agents using closed system drug transfer devices (CSTDs)

Satomi Sumikawa, Yoshihiro Yakushijin, Kenjiro Aogi et al. · Scientific Reports · 2022 · 12 citations · Full text

Phase II Study of Gemcitabine Monotherapy as a Salvage Treatment for Japanese Metastatic Breast Cancer Patients after Anthracycline and Taxane Treatment

Yuji Suzuki, Yukiko Tokuda, Yasuhiro Fujiwara et al. · Japanese Journal of Clinical Oncology · 2009 · 10 citations · Full text